معرفی
Bao-Zhu Yang is a Researcher at Yale School of Medicine, specializing in the Department of Psychiatry. With a PhD from University at Albany (2001), his work focuses on genetic mechanisms underlying psychiatric disorders.
- Positions: Research Scientist in Psychiatry
- Labs: Gelernter Lab, Division of Human Genetics
His research explores gene-environment interactions, admixture mapping, and comorbid substance use-depression using linkage/association methods. Supported by NIH K01 funding, he investigates genetic bases for conditions including childhood depression, alcoholism, and PTSD.
Recent publications highlight:
- Microbiome studies in methamphetamine use disorder (2023-2025)
- Genetic polymorphism analyses in NGF and GABAergic pathways (2020-2024)
- Network approaches to nicotine-alcohol comorbidity (2019)
- Epigenetic research on child maltreatment effects (2020)
Scientific Recognition:
- Young Investigator Award (2011) from NARSAD Brain and Behavior Research Foundation
Active grant support includes NIH K01 career development award for gene-mapping in comorbid disorders. Collaborates with leading researchers including Joel Gelernter and Hongyu Zhao across 30+ joint publications. His work spans 15+ years with recent focus on integrative -omics approaches to addiction psychiatry.
Based at 300 George St, New Haven, CT, Yang's laboratory work involves genetic epidemiology, transcriptomic integration, and neurogenetic mapping of substance use disorders.
